Key Points
- CEO Leslie Trigg sold 3,361 shares on Feb. 17 at $3.35 for $11,259.35, reducing her stake by 3.18% to 102,342 shares (SEC filing disclosed).
- Trigg has made multiple recent sales (Jan. 7, Jan. 20, Jan. 21 and Feb. 17), totaling roughly $90,000 of stock sold over that period.
- Outset Medical shares traded down ~2% to $3.46 (market cap ~$63.4M), sit near a 52-week low of $3.10, and carry a mixed analyst picture with a consensus rating of “Moderate Buy” and an average price target of $10.00.
Outset Medical, Inc. (NASDAQ:OM - Get Free Report) CEO Leslie Trigg sold 3,361 shares of Outset Medical stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $3.35, for a total value of $11,259.35. Following the sale, the chief executive officer directly owned 102,342 shares of the company's stock, valued at approximately $342,845.70. This trade represents a 3.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Leslie Trigg also recently made the following trade(s):
- On Wednesday, January 21st, Leslie Trigg sold 2,120 shares of Outset Medical stock. The shares were sold at an average price of $5.05, for a total value of $10,706.00.
- On Tuesday, January 20th, Leslie Trigg sold 11,794 shares of Outset Medical stock. The stock was sold at an average price of $5.12, for a total value of $60,385.28.
- On Wednesday, January 7th, Leslie Trigg sold 1,795 shares of Outset Medical stock. The shares were sold at an average price of $4.27, for a total value of $7,664.65.
Outset Medical Trading Down 2.0%
Outset Medical stock traded down $0.07 during midday trading on Friday, hitting $3.46. 120,908 shares of the stock were exchanged, compared to its average volume of 1,171,142. The stock has a market capitalization of $63.35 million, a PE ratio of -0.51 and a beta of 2.08. The company has a fifty day simple moving average of $4.34 and a two-hundred day simple moving average of $9.06. The company has a quick ratio of 5.77, a current ratio of 6.67 and a debt-to-equity ratio of 0.76. Outset Medical, Inc. has a 52 week low of $3.10 and a 52 week high of $21.98.
Analyst Upgrades and Downgrades
OM has been the subject of a number of recent analyst reports. Royal Bank Of Canada restated a "sector perform" rating and issued a $7.00 price objective on shares of Outset Medical in a research report on Wednesday, December 17th. Weiss Ratings restated a "sell (e+)" rating on shares of Outset Medical in a report on Monday, December 29th. Wall Street Zen lowered Outset Medical from a "hold" rating to a "sell" rating in a research report on Sunday, February 8th. Stifel Nicolaus cut their price objective on Outset Medical from $14.00 to $8.00 and set a "buy" rating on the stock in a report on Wednesday, January 7th. Finally, BTIG Research lowered their target price on Outset Medical from $17.00 to $15.00 and set a "buy" rating for the company in a research note on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $10.00.
Read Our Latest Stock Report on OM
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of OM. Legal & General Group Plc acquired a new stake in Outset Medical in the 2nd quarter valued at approximately $34,000. Ameritas Investment Partners Inc. acquired a new position in Outset Medical during the 2nd quarter worth approximately $35,000. BNP Paribas Financial Markets lifted its position in shares of Outset Medical by 7,013.8% in the second quarter. BNP Paribas Financial Markets now owns 2,063 shares of the company's stock worth $40,000 after purchasing an additional 2,034 shares in the last quarter. Police & Firemen s Retirement System of New Jersey acquired a new stake in Outset Medical in the 2nd quarter valued at $78,000. Finally, New York State Common Retirement Fund acquired a new position in shares of Outset Medical during the 2nd quarter worth about $108,000.
Outset Medical Company Profile
(
Get Free Report)
Outset Medical is a medical technology company specializing in innovations for renal care. The company's flagship offering, the Tablo Hemodialysis System, is designed to streamline and simplify dialysis treatment across acute and outpatient settings. By integrating water purification, dialysate production, and treatment monitoring into a single device, Tablo aims to reduce the complexity and logistical burden traditionally associated with hemodialysis therapy.
Tablo's modular design allows for rapid setup and flexible deployment in hospitals, clinics, long‐term care facilities and emergency response scenarios.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
